{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:27:05Z","timestamp":1740126425094,"version":"3.37.3"},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T00:00:00Z","timestamp":1671667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,22]]},"abstract":"<jats:p>Eczematous drug eruption during biological treatments represents novel and difficult-to-manage reactions, with a still unexplained pathogenesis<\/jats:p>\n               <jats:p>In patients treated with IL-17 inhibitors for psoriasis, eczematous drug eruptions skin lesions mainly express Th2\/Th22 features, with a central role played by IL-22.<\/jats:p>","DOI":"10.1093\/ced\/llac130","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T04:34:23Z","timestamp":1673498063000},"page":"396-397","source":"Crossref","is-referenced-by-count":0,"title":["Author reply to: Comment on: \u2018Eczematous drug eruption in patients with psoriasis under anti-interleukin-17A: does interleukin-22 play a key role?\u2019"],"prefix":"10.1093","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4658-7391","authenticated-orcid":false,"given":"Angelo","family":"Ruggiero","sequence":"first","affiliation":[{"name":"Section of Dermatology, Department of Clinical Medicine and Surgery and Department of Advanced Biomedical Sciences, University of Naples Federico II , Naples , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Megna","sequence":"additional","affiliation":[{"name":"Section of Dermatology, Department of Clinical Medicine and Surgery and Department of Advanced Biomedical Sciences, University of Naples Federico II , Naples , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppina","family":"Caiazzo","sequence":"additional","affiliation":[{"name":"Section of Dermatology, Department of Clinical Medicine and Surgery and Department of Advanced Biomedical Sciences, University of Naples Federico II , Naples , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melania","family":"Parisi","sequence":"additional","affiliation":[{"name":"Section of Dermatology, Department of Clinical Medicine and Surgery and Department of Advanced Biomedical Sciences, University of Naples Federico II , Naples , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Mascolo","sequence":"additional","affiliation":[{"name":"Pathology Unit, Department of Advanced Biomedical Sciences, University of Naples Federico II , Naples , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Russo","sequence":"additional","affiliation":[{"name":"Pathology Unit, Department of Advanced Biomedical Sciences, University of Naples Federico II , Naples , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Gallo","sequence":"additional","affiliation":[{"name":"Section of Dermatology, Department of Clinical Medicine and Surgery and Department of Advanced Biomedical Sciences, University of Naples Federico II , Naples , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Fabbrocini","sequence":"additional","affiliation":[{"name":"Section of Dermatology, Department of Clinical Medicine and Surgery and Department of Advanced Biomedical Sciences, University of Naples Federico II , Naples , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maddalena","family":"Napolitano","sequence":"additional","affiliation":[{"name":"Department of Medicine and Health Sciences Vincenzo Tiberio, University of Molise , Campobasso , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cataldo","family":"Patruno","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University Magna Graecia of Catanzaro , Catanzaro , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,12,22]]},"reference":[{"key":"2023100315295453700_llac130-B1","doi-asserted-by":"crossref","DOI":"10.1111\/ced.15386","article-title":"Comment on: \u2018Eczematous drug eruption in patients with psoriasis under anti-interleukin-17A: does interleukin-22 play a key role?\u2019","volume":"47","author":"Li","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"2023100315295453700_llac130-B2","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/ced.15052","article-title":"Eczematous drug eruption in patients with psoriasis under anti-interleukin-17A: does \u00adinterleukin-22 play a key role?","volume":"47","author":"Megna","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"2023100315295453700_llac130-B3","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s40257-021-00586-8","article-title":"Eczematous drug eruptions","volume":"22","author":"Blum","year":"2021","journal-title":"Am J Clin Dermatol"},{"key":"2023100315295453700_llac130-B4","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1080\/14712598.2020.1727439","article-title":"Clinical and histopathological characterization of eczematous eruptions occurring in course of anti IL-17 treatment: a case series and review of the literature","volume":"20","author":"Caldarola","year":"2020","journal-title":"Expert Opin Biol Ther"},{"key":"2023100315295453700_llac130-B5","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/bjd.17779","article-title":"Eczematous eruption during anti-interleukin 17 treatment of psoriasis: an emerging condition","volume":"181","author":"Napolitano","year":"2019","journal-title":"Br J Dermatol"},{"key":"2023100315295453700_llac130-B6","doi-asserted-by":"crossref","first-page":"e12751","DOI":"10.1111\/dth.12751","article-title":"Atopic-like dermatitis after secukinumab injection: a case report","volume":"32","author":"Burlando","year":"2019","journal-title":"Dermatol Ther"},{"key":"2023100315295453700_llac130-B7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2147\/CCID.S165605","article-title":"Spotlight on brodalumab in the treatment of plaque psoriasis: the evidence to date","volume":"12","author":"Galluzzo","year":"2019","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"1S","key":"2023100315295453700_llac130-B8","doi-asserted-by":"crossref","first-page":"e86\u20138","DOI":"10.1097\/DER.0000000000000645","article-title":"Concurrent atopic dermatitis and psoriasis successfully treated with brodalumab","volume":"32","author":"Gambardella","year":"2021","journal-title":"Dermatitis"},{"key":"2023100315295453700_llac130-B9","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1684\/ejd.2020.3904","article-title":"Successful switching to brodalumab in a patient with severe psoriasis developing ixekizumab-induced eczema","volume":"30","author":"Kimura","year":"2020","journal-title":"Eur J Dermatol"},{"key":"2023100315295453700_llac130-B10","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1684\/ejd.2020.3910","article-title":"Brodalumab-associated generalized eczematous eruption in a difficult-to-treat psoriasis patient: management without brodalumab withdrawal","volume":"30","author":"Danset","year":"2020","journal-title":"Eur J Dermatol"},{"key":"2023100315295453700_llac130-B11","doi-asserted-by":"crossref","first-page":"e15839","DOI":"10.1111\/dth.15839","article-title":"Eczematous eruption after brodalumab successfully treated with guselkumab and dupilumab","volume":"35","author":"Megna","year":"2022","journal-title":"Dermatol Ther"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llac130\/48623599\/llac130.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/48\/4\/396\/51836552\/llac130.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/48\/4\/396\/51836552\/llac130.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T17:23:02Z","timestamp":1696353782000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/48\/4\/396\/6957328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,22]]},"references-count":11,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,12,22]]},"published-print":{"date-parts":[[2023,3,22]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llac130","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"type":"print","value":"0307-6938"},{"type":"electronic","value":"1365-2230"}],"subject":[],"published-other":{"date-parts":[[2023,4]]},"published":{"date-parts":[[2022,12,22]]}}}